Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Abstract Background Interpretation of rituximab efficacy for refractory idiopathic inflammatory myopathies (IIM) is hampered by the absence of a uniform definition of refractory myositis and clinical response. Therefore, rigorous criteria of refractoriness, together with a homogenous definition of c...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2018-09-01
|
| coleção: | Advances in Rheumatology |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s42358-018-0030-z |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|